Quick Answer
Trevi Therapeutics, Inc. reported Shares Outstanding of 128.31 million shares for fiscal year 2025.
Trevi Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 128.31M | +37.1% |
| 2024 | 93.60M | +37.1% |
| 2023 | 68.28M | +13.9% |
| 2022 | 59.94M | +110.3% |
| 2021 | 28.51M | +53.7% |
| 2020 | 18.55M | +4.0% |
| 2019 | 17.83M | +3966.2% |
| 2018 | 438,600 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 128.22M | +69.9% | +5.3% |
| June 30, 2025 | 121.78M | +67.8% | +21.9% |
| March 31, 2025 | 99.89M | +44.9% | +6.7% |
| December 31, 2024 | 93.60M | +37.1% | +24.1% |
| September 30, 2024 | 75.45M | +18.2% | +3.9% |
| June 30, 2024 | 72.59M | +15.0% | +5.3% |
| March 31, 2024 | 68.96M | +14.8% | +1.0% |
| December 31, 2023 | 68.28M | +13.9% | +6.9% |
- Trevi Therapeutics, Inc. showed an increase of +37.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Trevi Therapeutics, Inc.’s shares outstanding has grown by 29153.5% (from 438.6 thousand shares to 128.31 million shares).
- The most recent figure is from Trevi Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: